Endovia Health Sciences, Inc.
EDVA
25 hedge funds and large institutions have $2.93M invested in Endovia Health Sciences, Inc. in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
25% more funds holding
Funds holding: 20 → 25 (+5)
0.01% more ownership
Funds ownership: 0.03% → 0.04% (+0.01%)
15% less capital invested
Capital invested by funds: $3.45M → $2.93M (-$515K)
63% less call options, than puts
Call options by funds: $11K | Put options by funds: $30K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$162K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$147K |
| 3 |
Renaissance Technologies
New York
|
+$55.4K |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$50.1K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$41.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5.85K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.92K |
EDVA Hedge Fund Activity: Q2 2023 in Review
25 of the 6,382 institutional investors tracked by Wall St. Rank reported a position in Endovia Health Sciences, Inc. (EDVA) for Q2 2023, worth a combined $2.93M — down 15% from $3.45M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new EDVA positions and 0 closed out — a net gain of 5 holders — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $162K. The largest seller was Tower Research Capital (TRC), cutting an estimated $10.4K.
- 25 institutional investors held Endovia Health Sciences, Inc. (EDVA) as of Q2 2023, up from 20 in Q1 2023.
- Funds reported $2.93M of Endovia Health Sciences, Inc. stock for Q2 2023, down 15% quarter-over-quarter.
- 5 funds opened new Endovia Health Sciences, Inc. positions in Q2 2023 and 0 closed out, a net change of +5 holders.
- The largest Endovia Health Sciences, Inc. buyer in Q2 2023 was Susquehanna International Group, an estimated $162K added.
- The largest Endovia Health Sciences, Inc. seller in Q2 2023 was Tower Research Capital (TRC), an estimated $10.4K sold.
Based on aggregated 13F filings for Q2 2023.